Logo image of HSAI

HESAI GROUP (HSAI) Stock Fundamental Analysis

NASDAQ:HSAI - Nasdaq - US4280501085 - ADR - Currency: USD

20  +0.42 (+2.15%)

After market: 20 0 (0%)

Fundamental Rating

4

Taking everything into account, HSAI scores 4 out of 10 in our fundamental rating. HSAI was compared to 81 industry peers in the Automobile Components industry. The financial health of HSAI is average, but there are quite some concerns on its profitability. HSAI is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

HSAI had positive earnings in the past year.
In the past 5 years HSAI always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: HSAI reported negative operating cash flow in multiple years.
HSAI Yearly Net Income VS EBIT VS OCF VS FCFHSAI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -500M -1B -1.5B -2B

1.2 Ratios

With a Return On Assets value of -0.23%, HSAI is not doing good in the industry: 72.84% of the companies in the same industry are doing better.
HSAI has a worse Return On Equity (-0.31%) than 71.60% of its industry peers.
Industry RankSector Rank
ROA -0.23%
ROE -0.31%
ROIC N/A
ROA(3y)-9.86%
ROA(5y)-19.98%
ROE(3y)-13.74%
ROE(5y)-26.23%
ROIC(3y)N/A
ROIC(5y)N/A
HSAI Yearly ROA, ROE, ROICHSAI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

HSAI has a Gross Margin of 42.99%. This is amongst the best in the industry. HSAI outperforms 97.53% of its industry peers.
HSAI's Gross Margin has declined in the last couple of years.
HSAI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 42.99%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.03%
GM growth 5Y-9.55%
HSAI Yearly Profit, Operating, Gross MarginsHSAI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

More info and screens

6

2. Health

2.1 Basic Checks

HSAI does not have a ROIC to compare to the WACC, probably because it is not profitable.
HSAI has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, HSAI has more shares outstanding
HSAI has a worse debt/assets ratio than last year.
HSAI Yearly Shares OutstandingHSAI Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
HSAI Yearly Total Debt VS Total AssetsHSAI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

HSAI has an Altman-Z score of 7.42. This indicates that HSAI is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of HSAI (7.42) is better than 93.83% of its industry peers.
HSAI has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.08, HSAI belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Altman-Z 7.42
ROIC/WACCN/A
WACC8.27%
HSAI Yearly LT Debt VS Equity VS FCFHSAI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

HSAI has a Current Ratio of 4.06. This indicates that HSAI is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of HSAI (4.06) is better than 91.36% of its industry peers.
HSAI has a Quick Ratio of 3.62. This indicates that HSAI is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 3.62, HSAI belongs to the top of the industry, outperforming 93.83% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.06
Quick Ratio 3.62
HSAI Yearly Current Assets VS Current LiabilitesHSAI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

More info and screens

8

3. Growth

3.1 Past

HSAI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 126.02%, which is quite impressive.
Looking at the last year, HSAI shows a very strong growth in Revenue. The Revenue has grown by 24.20%.
Measured over the past years, HSAI shows a very strong growth in Revenue. The Revenue has been growing by 42.94% on average per year.
EPS 1Y (TTM)126.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%111.11%
Revenue 1Y (TTM)24.2%
Revenue growth 3Y42.3%
Revenue growth 5Y42.94%
Sales Q2Q%46.27%

3.2 Future

Based on estimates for the next years, HSAI will show a very strong growth in Earnings Per Share. The EPS will grow by 215.94% on average per year.
HSAI is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 40.22% yearly.
EPS Next Y6505.34%
EPS Next 2Y1085.86%
EPS Next 3Y478.81%
EPS Next 5Y215.94%
Revenue Next Year59.18%
Revenue Next 2Y51.86%
Revenue Next 3Y44.03%
Revenue Next 5Y40.22%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
HSAI Yearly Revenue VS EstimatesHSAI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5B 10B 15B 20B 25B
HSAI Yearly EPS VS EstimatesHSAI Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 0 5 -5 10

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 222.22, HSAI can be considered very expensive at the moment.
Based on the Price/Earnings ratio, HSAI is valued more expensive than 80.25% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.52, HSAI is valued quite expensively.
Based on the Price/Forward Earnings ratio of 25.53, the valuation of HSAI can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of HSAI indicates a slightly more expensive valuation: HSAI is more expensive than 75.31% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.25, HSAI is valued at the same level.
Industry RankSector Rank
PE 222.22
Fwd PE 25.53
HSAI Price Earnings VS Forward Price EarningsHSAI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, HSAI is valued more expensive than 85.19% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 581.88
HSAI Per share dataHSAI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
HSAI's earnings are expected to grow with 478.81% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.03
PEG (5Y)N/A
EPS Next 2Y1085.86%
EPS Next 3Y478.81%

More info and screens

0

5. Dividend

5.1 Amount

HSAI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HESAI GROUP

NASDAQ:HSAI (6/6/2025, 8:00:02 PM)

After market: 20 0 (0%)

20

+0.42 (+2.15%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)05-26 2025-05-26/amc
Earnings (Next)N/A N/A
Inst Owners51.31%
Inst Owner Change24.73%
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap2.65B
Analysts85.71
Price Target25.34 (26.7%)
Short Float %4.77%
Short Ratio0.86
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)66.12%
Min EPS beat(2)-13.01%
Max EPS beat(2)145.25%
EPS beat(4)2
Avg EPS beat(4)10.14%
Min EPS beat(4)-108.33%
Max EPS beat(4)145.25%
EPS beat(8)6
Avg EPS beat(8)21.71%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.85%
Min Revenue beat(2)-3.22%
Max Revenue beat(2)-2.48%
Revenue beat(4)1
Avg Revenue beat(4)-0.64%
Min Revenue beat(4)-4.88%
Max Revenue beat(4)8.02%
Revenue beat(8)4
Avg Revenue beat(8)2.26%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)55.48%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)6.7%
EPS NY rev (3m)60.74%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.09%
Revenue NY rev (3m)0.46%
Valuation
Industry RankSector Rank
PE 222.22
Fwd PE 25.53
P/S 8.48
P/FCF N/A
P/OCF N/A
P/B 4.45
P/tB 4.53
EV/EBITDA 581.88
EPS(TTM)0.09
EY0.45%
EPS(NY)0.78
Fwd EY3.92%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.36
BVpS4.5
TBVpS4.41
PEG (NY)0.03
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.23%
ROE -0.31%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 42.99%
FCFM N/A
ROA(3y)-9.86%
ROA(5y)-19.98%
ROE(3y)-13.74%
ROE(5y)-26.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.03%
GM growth 5Y-9.55%
F-ScoreN/A
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Debt/EBITDA 10.73
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.06
Quick Ratio 3.62
Altman-Z 7.42
F-ScoreN/A
WACC8.27%
ROIC/WACCN/A
Cap/Depr(3y)378.06%
Cap/Depr(5y)506.05%
Cap/Sales(3y)18.38%
Cap/Sales(5y)22.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)126.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%111.11%
EPS Next Y6505.34%
EPS Next 2Y1085.86%
EPS Next 3Y478.81%
EPS Next 5Y215.94%
Revenue 1Y (TTM)24.2%
Revenue growth 3Y42.3%
Revenue growth 5Y42.94%
Sales Q2Q%46.27%
Revenue Next Year59.18%
Revenue Next 2Y51.86%
Revenue Next 3Y44.03%
Revenue Next 5Y40.22%
EBIT growth 1Y82.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year262.82%
EBIT Next 3Y89.56%
EBIT Next 5Y71.49%
FCF growth 1Y42.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y11.77%
OCF growth 3YN/A
OCF growth 5Y6.75%